Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Sustained long‐term efficacy and safety of adalimumab in paediatric patients with severe chronic plaque psoriasis from a randomized, double‐blind, phase III study
Diamant Thaçi, Kim Papp, Danielle Marcoux, et al.
British Journal of Dermatology (2019) Vol. 181, Iss. 6, pp. 1177-1189
Open Access | Times Cited: 34

Showing 1-25 of 34 citing articles:

Adverse events with risankizumab in the real world: postmarketing pharmacovigilance assessment of the FDA adverse event reporting system
Yamin Shu, Jing Chen, Yiling Ding, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 24
Emerging treatments for dermatologic diseases in infants, children, and adolescents: a systematic review of clinical trials on biologics and small molecule inhibitors
Alireza Jafarzadeh, Elham Behrangi, Mina Khosravi, et al.
Inflammopharmacology (2025) Vol. 33, Iss. 4, pp. 1617-1672
Closed Access
Hidradenitis suppurativa in pediatric patients
Ellie Choi, Xue Ting Ooi, Nisha Suyien Chandran
Journal of the American Academy of Dermatology (2020) Vol. 86, Iss. 1, pp. 140-147
Closed Access | Times Cited: 34
Update on the Management of Pediatric Psoriasis: An Italian Consensus
Ketty Peris, Anna Belloni Fortina, Luca Bianchi, et al.
Dermatology and Therapy (2022) Vol. 12, Iss. 8, pp. 1753-1775
Open Access | Times Cited: 19
Childhood guttate psoriasis: an updated review
Alexander K. C. Leung, Benjamin Barankin, Joseph M. Lam, et al.
Drugs in Context (2023) Vol. 12, pp. 1-20
Open Access | Times Cited: 10
Adalimumab in severe plaque psoriasis of childhood: A multi‐center, retrospective real‐life study up to 52 weeks observation
Vito Di Lernia, Luca Bianchi, Cristina Guerriero, et al.
Dermatologic Therapy (2019) Vol. 32, Iss. 6
Open Access | Times Cited: 29
Managing pediatric psoriasis: update on treatments and challenges—a review
Adelaide A. Hebert, John Browning, P. C. Kwong, et al.
Journal of Dermatological Treatment (2022) Vol. 33, Iss. 5, pp. 2433-2442
Open Access | Times Cited: 14
TNF-Alpha Inhibitors and Ustekinumab for the Treatment of Psoriasis: Therapeutic Utility in the Era of IL-17 and IL-23 Inhibitors
Julie Hong, Edward Hadeler, Megan Mosca, et al.
Journal of Psoriasis and Psoriatic Arthritis (2022) Vol. 7, Iss. 2, pp. 79-92
Open Access | Times Cited: 11
Biologics for pediatric moderate‐to‐severe plaque psoriasis: a systematic review and network meta‐analysis
I‐Hsin Huang, Chia‐Ling Yu, Cheng‐Chen Tai, et al.
JDDG Journal der Deutschen Dermatologischen Gesellschaft (2022) Vol. 20, Iss. 9, pp. 1201-1209
Closed Access | Times Cited: 10
Targeted Therapy for Pediatric Psoriasis
Miguel Nogueira, Amy S. Paller, Tiago Torres
Pediatric Drugs (2021) Vol. 23, Iss. 3, pp. 203-212
Closed Access | Times Cited: 14
Adalimumab in children and adolescents with severe plaque psoriasis: a safety evaluation
Arianna Zangrilli, Mauro Bavetta, Luca Bianchi
Expert Opinion on Drug Safety (2020) Vol. 19, Iss. 4, pp. 433-438
Closed Access | Times Cited: 14
Perspectives on the pharmacological management of psoriasis in pediatric and adolescent patients
E. Mahé, M. Amy de la Bretèque, C. Phan
Expert Review of Clinical Pharmacology (2021) Vol. 14, Iss. 7, pp. 807-819
Closed Access | Times Cited: 12
Evolving Landscape of Biologic Therapy for Pediatric Psoriasis
Huongly Do, Kayla Babbush Graber, Karen A. Chernoff, et al.
Dermatologic Clinics (2024) Vol. 42, Iss. 3, pp. 377-386
Closed Access | Times Cited: 1
Off-Label Treatments for Pediatric Psoriasis: Lessons for the Clinic
Morten Bahrt Haulrig, Claus Zachariae, Lone Skov
Psoriasis Targets and Therapy (2021) Vol. Volume 11, pp. 1-20
Open Access | Times Cited: 8
De-Escalation of Anti-Tumor Necrosis Factor Alpha Agents and Reduction in Adverse Effects: A Systematic Review
Marleen Bouhuys, Willem S. Lexmond, Patrick F. van Rheenen
Biomedicines (2022) Vol. 10, Iss. 5, pp. 1034-1034
Open Access | Times Cited: 5
Management Strategies for Pediatric Moderate-to-Severe Plaque Psoriasis: Spotlight on Biologics
Angelo Ruggiero, Antonio Portarapillo, Matteo Megna, et al.
Pediatric Health Medicine and Therapeutics (2023) Vol. Volume 14, pp. 435-451
Open Access | Times Cited: 2
Therapeutic challenges in managing pediatric psoriasis
Yamila Goenaga-Vázquez, Kyle C. Lauck, Adelaide A. Hebert
International Journal of Women’s Dermatology (2020) Vol. 7, Iss. 3, pp. 314-318
Open Access | Times Cited: 5
Refractory Pediatric Psoriasis and Atopic Dermatitis: The Importance of Therapeutical Adherence and Biological Management
Katherine A. Kelly, Adaora Ewulu, Veronica K. Emmerich, et al.
Biomedicines (2021) Vol. 9, Iss. 8, pp. 958-958
Open Access | Times Cited: 5
How can we optimize the use of methotrexate to treat pediatric patients with inflammatory skin diseases?
Kajetan Kiełbowski, Estera Bakinowska, Andrzej Pawlik
Expert Opinion on Drug Metabolism & Toxicology (2024) Vol. 20, Iss. 3, pp. 111-118
Closed Access
Documento de consenso del Grupo Español de Psoriasis (GPS) y del grupo Español de Dermatología Pediátrica (GEDP) de la Academia Española de Dermatología y Venereología (AEDV) sobre el manejo de la psoriasis pediátrica
A. Vicente, A. Pérez‐Ferriols, A. Batalla, et al.
Actas Dermo-Sifiliográficas (2024)
Open Access
Comparison of adalimumab with methotrexate for psoriasis: A meta-analysis of randomized controlled studies
Xiaolin Yang, Yan Liu
Medicine (2024) Vol. 103, Iss. 32, pp. e37216-e37216
Open Access
Biologicals for moderate-to-severe plaque type psoriasis in pediatric patients
Florence Libon, Eve Lebas, Virginie de Schaetzen, et al.
Expert Review of Clinical Immunology (2021) Vol. 17, Iss. 9, pp. 947-955
Closed Access | Times Cited: 3
Challenges in the treatment of psoriasis in childhood
Klara Cvenkel, Mateja Starbek Zorko
Acta Dermatovenerologica Alpina Pannonica et Adriatica (2021) Vol. 30, Iss. 3
Closed Access | Times Cited: 3
Importance and prospects of studying survival of genetically engineered biological therapy for psoriasis in children
Roman A. Ivanov
Medical alphabet (2022), Iss. 8, pp. 80-85
Closed Access | Times Cited: 2
Systemic Treatments in Pediatric Psoriasis: A Retrospective Single-Center Study
Gökhan Şahin, Fatma Aydın, Esra Pancar Yüksel
Archives of Iranian Medicine (2021) Vol. 24, Iss. 12, pp. 903-909
Open Access | Times Cited: 2
Page 1 - Next Page

Scroll to top